MAPK8 and plasma cell myeloma: Both the PSMC6 and MAPK8 genes were upregulated in melanosis coli patients [40], and CRISPR Genome-Wide Screening demonstrated that the PSMC6 subunit is an important and sensitive target for bortezomib in multiple myeloma cells [41].